Related Experiment Video
Updated: Jan 20, 2026

Author Spotlight: Capturing Infant-Caregiver Interactions Through Synchronized Multimodal Data Collection
Published on: May 31, 2024
Unravelling myelofibrosis in infants: A hidden pediatric challenge!
Shalini Singh1, Priyavadhana Balasubramanian1, Zahed Ali Qamer1
1Department of Pathology and Laboratory Medicine, All India Institute of Medical Sciences (AIIMS), Rishikesh, Uttarakhand, India.
Insights
This case report emphasizes identifying acute megakaryoblastic leukemia (AMKL) in infants, even with fibrotic bone marrow. Early detection is crucial for managing this rare pediatric cancer.
Area of Science:
- Pediatric Hematology
- Oncology
- Cytogenetics
Background:
- Infantile acute megakaryoblastic leukemia (AMKL) is a rare and aggressive subtype of acute myeloid leukemia.
- Diagnosis can be challenging, particularly in cases with myelofibrosis, which may obscure the presence of leukemic blasts.
Purpose of the Study:
- To highlight the diagnostic challenges of AMKL in the context of myelofibrosis.
- To underscore the importance of thorough bone marrow examination, including repeat aspirations and advanced techniques, for accurate diagnosis.
Main Methods:
- Case presentation of a 6-month-old infant with fever, hepatosplenomegaly, and initial negative bone marrow cultures.
- Bone marrow aspiration and biopsy revealing myelofibrosis and suppressed hematopoiesis.
- Repeat bone marrow aspiration, immunophenotyping (flow cytometry), and cytogenetic analysis identifying AMKL with Trisomy 8 and 19.
Main Results:
- Initial bone marrow aspiration yielded a dry tap, with biopsy showing myelofibrosis.
- Repeat aspiration revealed 22% blasts, confirmed as AMKL by flow cytometry.
- Cytogenetic analysis showed Trisomy 8 and 19.
Conclusions:
- Myelofibrosis can mask AMKL, necessitating careful evaluation of bone marrow samples.
- Early and accurate diagnosis through comprehensive methods like immunophenotyping and cytogenetics is vital for appropriate management of infantile AMKL.
- This case underscores the need to suspect AMKL even with initial non-diagnostic bone marrow findings.
Abstract:
A 6-month-old boy presented with complaints of irritability, decreased feeding and high-grade intermittent fever for 20 days. He had moderate hepatosplenomegaly. Baseline cultures were negative but urinary Cytomegalovirus polymerase chain reaction was positive. He was started on Inj. Ganciclovir 5 mg/kg/dose twice daily for 14 days. Bone marrow aspiration (BMA) yielded a dry tap. Bone marrow biopsy (BMB) showed marked myelofibrosis with suppressed trilineage hematopoiesis. In view of persistent cytopenia and fever, a repeat BMA was done, revealing 22% blasts. Immunophenotyping by flow cytometry revealed 5.4% blasts with megakaryocytic differentiation. Subsequent cytogenetic analysis revealed Trisomy 8 and 19, with no evidence of Down syndrome. He was started on Down syndrome AML induction therapy followed by Cytarabine-Idarubicin-Etoposide therapy, but ultimately, he succumbed to infection and persistent disease. This case highlights the significance of looking for blasts even in a diluted marrow, so AMKL in a fibrotic marrow will not be missed.
Related Concept Videos
08:08Home-Based EEG Hyperscanning for Infant-Caregiver Social Interactions
08:20A Within-subjects Experimental Protocol to Assess the Effects of Social Input on Infant EEG
08:22Measuring Cardiac Autonomic Nervous System (ANS) Activity in Toddlers - Resting and Developmental Challenges
04:52Hand-Rearing Method for Infant Marmosets
11:19Guidelines for Elective Pediatric Fiberoptic Intubation
12:55P50 Sensory Gating in Infants

